4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles

      research-article
      1 , 2 , 1 , 3 , 1 , 4 , 3 , 1 , 3 , 1 , 2 , 1 , 5 , 3 , 1 , 2 , 3 , 6 , 6 , 7 , 8 , 3 , 3 , 3 , 9 , 3 , 10 , 11 , 3 , 3 , 3 , 3 , 5 , 12 , 5 , 13 , 1 , 14 , 1 , 1 , 6 , 15 , 1 , 1 , 9 , 3 , 2 , 6 , 15 , 16 , 17 , 18 , 6 , 15 , 2 , 19 , 20 , 3 , 1 , 14 , * ,
      Science Advances
      American Association for the Advancement of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Animal studies suggest that the apolipoprotein E ε4 ( APOEε4) allele is a culprit of early microglial activation in Alzheimer’s disease (AD). Here, we tested the association between APOEε4 status and microglial activation in living individuals across the aging and AD spectrum. We studied 118 individuals with positron emission tomography for amyloid-β (Aβ; [ 18F]AZD4694), tau ([ 18F]MK6240), and microglial activation ([ 11C]PBR28). We found that APOEε4 carriers presented increased microglial activation relative to noncarriers in early Braak stage regions within the medial temporal cortex accounting for Aβ and tau deposition. Furthermore, microglial activation mediated the Aβ-independent effects of APOEε4 on tau accumulation, which was further associated with neurodegeneration and clinical impairment. The physiological distribution of APOE mRNA expression predicted the patterns of APOEε4-related microglial activation in our population, suggesting that APOE gene expression may regulate the local vulnerability to neuroinflammation. Our results support that the APOEε4 genotype exerts Aβ-independent effects on AD pathogenesis by activating microglia in brain regions associated with early tau deposition.

          Abstract

          APOEε4 contributes to microglial activation in early Braak regions, promoting Alzheimer’s disease progression.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: not found
          • Article: not found

          lavaan: AnRPackage for Structural Equation Modeling

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

            The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia. Copyright © 2011. Published by Elsevier Inc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neuropathological stageing of Alzheimer-related changes

              Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes. The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages. Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads. The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another. Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages. The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II). The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex. In addition, there was mild involvement of the first Ammon's horn sector. The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas. The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: SoftwareRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: Data curationRole: Formal analysisRole: InvestigationRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: MethodologyRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: MethodologyRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: MethodologyRole: SoftwareRole: Writing - review & editing
                Role: ConceptualizationRole: MethodologyRole: SoftwareRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: ValidationRole: Writing - review & editing
                Role: InvestigationRole: ValidationRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: SoftwareRole: VisualizationRole: Writing - original draft
                Role: Data curationRole: Project administrationRole: ResourcesRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: Resources
                Role: InvestigationRole: Project administrationRole: ResourcesRole: Supervision
                Role: Data curationRole: SoftwareRole: Writing - review & editing
                Role: Data curationRole: Formal analysisRole: SoftwareRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: Data curationRole: Formal analysisRole: InvestigationRole: ResourcesRole: Validation
                Role: Project administration
                Role: InvestigationRole: Project administrationRole: Supervision
                Role: Investigation
                Role: Data curationRole: InvestigationRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: InvestigationRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: MethodologyRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draft
                Role: ConceptualizationRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: VisualizationRole: Writing - review & editing
                Role: Formal analysis
                Role: Funding acquisitionRole: InvestigationRole: MethodologyRole: ResourcesRole: ValidationRole: Writing - review & editing
                Role: ConceptualizationRole: SupervisionRole: Writing - review & editing
                Role: SupervisionRole: Writing - review & editing
                Role: InvestigationRole: Writing - review & editing
                Role: MethodologyRole: Visualization
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: ResourcesRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: Writing - review & editing
                Role: InvestigationRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: MethodologyRole: Project administrationRole: ResourcesRole: SoftwareRole: SupervisionRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - review & editing
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                April 2023
                05 April 2023
                : 9
                : 14
                : eade1474
                Affiliations
                [ 1 ]Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.
                [ 2 ]Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
                [ 3 ]Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
                [ 4 ]ADHD Outpatient Program and Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
                [ 5 ]Department of Clinical Neurosciences, Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, UK.
                [ 6 ]Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
                [ 7 ]Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
                [ 8 ]Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK.
                [ 9 ]Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
                [ 10 ]Artificial Intelligence and Computational Neurosciences lab, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
                [ 11 ]LC Campbell Cognitive Neurology Unit, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
                [ 12 ]Department of Psychiatry, University of Cambridge, Cambridge, UK.
                [ 13 ]MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.
                [ 14 ]Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.
                [ 15 ]Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
                [ 16 ]Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
                [ 17 ]UK Dementia Research Institute at UCL, London, UK.
                [ 18 ]Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
                [ 19 ]Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
                [ 20 ]Graduate Program in Biological Sciences: Pharmacology and Therapeuctis, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
                Author notes
                [* ]Corresponding author. Email: pascoalt@ 123456upmc.edu .
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0003-2183-1551
                https://orcid.org/0000-0002-6877-4825
                https://orcid.org/0000-0002-4890-8451
                https://orcid.org/0000-0002-7826-4781
                https://orcid.org/0000-0003-2711-3833
                https://orcid.org/0000-0002-2212-3373
                https://orcid.org/0000-0003-2134-9829
                https://orcid.org/0000-0001-8923-9656
                https://orcid.org/0000-0002-2023-6569
                https://orcid.org/0000-0001-8219-1741
                https://orcid.org/0000-0001-7001-5652
                https://orcid.org/0000-0002-4431-957X
                https://orcid.org/0000-0003-0745-6222
                https://orcid.org/0000-0002-0837-5080
                https://orcid.org/0000-0001-7216-8679
                https://orcid.org/0000-0002-8546-8256
                https://orcid.org/0000-0003-1422-4358
                https://orcid.org/0000-0003-3930-4354
                https://orcid.org/0000-0002-1890-4193
                https://orcid.org/0000-0002-5349-0053
                https://orcid.org/0000-0001-9116-1376
                https://orcid.org/0000-0001-9057-8014
                Article
                ade1474
                10.1126/sciadv.ade1474
                10075966
                37018391
                40f84fdc-791c-4472-95b3-d18ae12fa84e
                Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 27 July 2022
                : 02 March 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: #R01AG075336 and #R01AG073267
                Funded by: FundRef http://dx.doi.org/10.13039/100000874, Brain and Behavior Research Foundation;
                Award ID: #29486
                Funded by: FundRef http://dx.doi.org/10.13039/100012479, Weston Brain Institute;
                Funded by: FundRef http://dx.doi.org/10.13039/501100000024, Canadian Institutes of Health Research;
                Award ID: #MOP-11-51-31; RFN 152985, 159815, 162303
                Funded by: FundRef http://dx.doi.org/10.13039/501100003593, Conselho Nacional de Desenvolvimento Científico e Tecnológico;
                Award ID: #200691/2021-0
                Funded by: FundRef http://dx.doi.org/10.13039/501100003593, Conselho Nacional de Desenvolvimento Científico e Tecnológico;
                Award ID: #166407/2020-8
                Funded by: Canadian consortium of Neurodegeneration and aging;
                Award ID: #MOP-11-51-31 - team 1
                Funded by: Fonds de recherche du Québec – Santé;
                Funded by: Race Against Dementia Alzheimer’s Research UK;
                Award ID: #ARUK-RADF2021A-010
                Funded by: Fonds de recherche du Québec – Santé;
                Award ID: #2020-VICO-279314
                Funded by: Brain Canada Foundation;
                Award ID: CFI Project 34874; 33397
                Funded by: Alzheimer’s Association;
                Award ID: #NIRG-12-92090 and #NIRP-12-259245
                Funded by: Alzheimer’s Association;
                Award ID: #AACSF-20-648075
                Categories
                Research Article
                Neuroscience
                SciAdv r-articles
                Neuroscience
                Neuroscience
                Custom metadata
                Lou Notario

                Comments

                Comment on this article